Heart Failure

Finerenone Reduces Risk of Incident HF in Patients with T2D + CKD in FIGARO-DKD Analyses
December 15, 2021

Finerenone, the nonsteroidal mineralocorticoid receptor antagonist, significantly reduced new-onset HF and improved other HF outcomes in the FIGARO-DKD trial.

Obesity Linked to Elevated Risk of Heart Failure in Persons with Diabetes
December 10, 2021

Increases in obesity parameters significantly increased risk of incident heart failure in persons with diabetes, but not without diabetes, in a large community-based cohort study.

Aspirin Associated with Increased Risk for Incident Heart Failure in Large Patient-level Pooled Analysis
November 23, 2021

Treatment with aspirin of patients with cardiovascular risk factors was consistently associated with a greater than 25% risk of incident HF, another strike against the OTC antithrombotic.

First Sign of CVD in Smokers May be a Fatal MI or Stroke, New Study Finds
November 17, 2021

Smoking was associated with earlier onset of cardiovascular disease, by 5.1 years for men and 3.8 years for women, the new study found.

Canagliflozin Improved HF Symptoms, QOL Regardless of Diabetes Status in Fully Remote Clinical Trial
November 16, 2021

AHA 2021. Heart failure patients, across ejection fraction and diabetes status, reported improved QOL as early as 3 months in CHIEF-HF trial.

Population for Digital Heart Failure Coaching App May Need Rethinking
November 12, 2021

AHA Scientific Sessions 2021: New research provides a note of caution for the use of digital heart failure coaching apps in severely ill and elderly patients with unstable heart failure.

Heart Failure Drugs in the Pipeline: Six Novel Therapeutics to Note
October 27, 2021

Heart failure drugs in the pipeline now number more than 100 and include familiar names plus dozens of new ones. Get a top-line look at 6 of the most promising.

Omecamtiv Mecarbil Shows Promise in Patients with Severe Heart Failure
October 26, 2021

Results of a GALACTIC-HF post-hoc analysis suggest a role for omecamtiv mecarbil in an HF population that remains difficult to treat effectively.

A Heart Failure Research Roundup Quiz: 8 Questions
October 21, 2021

Advances in heart failure management, including inroads in treatment for HFpEF, are happening fast. Try 8 questions to find out how well you’ve been following the news.

Less than Half of Vulnerable Older Adults Monitor BP at Home
October 15, 2021

A survey of adults aged 50-80 years with hypertension and/ or related comorbidities found even among those with a BP monitor at home, less than 50% checked BP at least once a week.